Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.

J Pain Res · 2020 · PMC7735791 · PMID 33328761

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

However, at this early stage in a drug’s development, it is premature to reject an effective candidate due to marginal significance; a one-sided test was used whenever applicable due to the fact that the current analysis was interested in testing the benefits of ASP0819 over placebo as opposed to the benefits of placebo over ASP0819.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.